Eplemore T Tablet contains Eplerenone 25 mg and Torasemide 10 mg, a dual-action cardiovascular formulation designed for effective management of hypertension, edema, and heart failure.
Eplerenone acts as a selective aldosterone antagonist, reducing fluid retention, blood pressure, and cardiac workload, while Torasemide works as a loop diuretic, promoting excretion of excess water and sodium, alleviating edema and related cardiac stress.
Clinically, Eplemore T Tablet is indicated for hypertension, chronic heart failure, and fluid overload conditions, providing enhanced cardiac function, reduced swelling, and improved patient comfort. Its tablet formulation ensures accurate dosing, stability, and patient compliance.
From a business perspective, Eplemore T Tablet strengthens the cardiology therapy segment, widely used in cardiology clinics, hospitals, and specialty heart care centers, offering consistent demand, repeat prescriptions, and strong prescriber confidence.